The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks trim losses on Greek hopes, Chinese stimulus

Wed, 04th Feb 2015 17:09

A late rally helped the FTSE 100 to erase most of its losses on Wednesday as optimism surrounding Greece and stimulus measures in China lifted sentiment, though stocks still finished in the red after hitting a five-month high the previous day.London's Footsie ended the session down 0.2% at 6,860.02, bouncing strongly in the last couple of hours after hitting an intraday low of 6,804.10, with pharma heavyweight Glaxosmithkline rising after its results announcement.Greece's prime minister Alexis Tsipras said in a press conference that he believes a debt relief deal can be met without the country leaving the EU. Tsipras said despite not having a deal yet, the country is "moving in the right direction".The prime minister travelled to Brussels to propose the new government's debt-swap plan to EU Commission president Jean-Claude Juncker. Greece has backed down from calling for a total debt write-off and has instead proposed swapping outstanding debt for new growth-linked bonds.Meanwhile, Greek finance minister Yanis Varoufakis, who held a meeting in Frankfurt with European Central Bank head Mario Draghi, said that discussions about easing the terms of the country's bailout were "very fruitful".Elsewhere, the People's Bank of China (PBoC) trimmed the banks' reserve requirement ratio by 50 basis points to 19.5%, the first such cut since May 2012, in an effort to boost lending into the real economy.According to FXTM analyst Jameel Ahmad, the PBoC was the 16th central bank across the globe to ease monetary policy this year in a move that "will be seen by many as a direct response to continued indications of slowing domestic momentum". He said the cut in the reserve requirement will be judged "by the markets as a positive move to reinvigorate economic growth".A raft of service-sector data was released during Wednesday session, showing that growth had picked up in the UK, Eurozone and US but eased in China.Glaxo leads late rallySales, profits and earnings slumped during the last quarter of the year at drugmaker GlaxoSmithKline due to headwinds in the US market, though the company pleased investors after confirming it would return £4bn cash from its deal with Novartis.Others in the pharma sector was also in demand, such as Astrazeneca, Hikma and Synergy Health with the latter benefiting after reporting a solid acceleration in underlying revenue growth in its third quarter.In its first set of results since slimming down its name to Sky and absorbing its German and Italian sister companies, the satellite broadcaster delivered a strong set of interim figures and cited good momentum in all its markets, causing shares to rise.Half-yearly results from fund manager and savings outfit Hargreaves Lansdown showed record assets under administration and growing client numbers, though shares fell sharply after revenues and profits came in shy of City expectations.Oil stocks were stuck in the red as the recent rally in crude prices came to an end with Brent falling 2.9%. Shell, Tullow, Afren and BHP Billiton all declined. Market MoverstechMARK 3,083.09 +0.68%FTSE 100 6,860.02 -0.17%FTSE 250 16,571.64 +0.01%FTSE 100 - RisersITV (ITV) 230.60p +3.64%ARM Holdings (ARM) 1,069.00p +3.09%easyJet (EZJ) 1,778.00p +2.72%Wolseley (WOS) 3,888.00p +1.94%CRH (CRH) 1,779.00p +1.89%Barratt Developments (BDEV) 470.00p +1.78%GlaxoSmithKline (GSK) 1,476.00p +1.58%Ashtead Group (AHT) 1,079.00p +1.41%Burberry Group (BRBY) 1,796.00p +1.41%International Consolidated Airlines Group SA (CDI) (IAG) 542.00p +1.40%FTSE 100 - FallersHargreaves Lansdown (HL.) 966.00p -7.56%Tullow Oil (TLW) 395.90p -5.15%Morrison (Wm) Supermarkets (MRW) 181.50p -2.42%Sainsbury (J) (SBRY) 266.70p -2.16%BHP Billiton (BLT) 1,527.00p -2.02%Aggreko (AGK) 1,596.00p -1.84%Anglo American (AAL) 1,150.00p -1.71%BG Group (BG.) 932.00p -1.38%Intertek Group (ITRK) 2,398.00p -1.28%SABMiller (SAB) 3,528.50p -1.27%FTSE 250 - RisersRank Group (RNK) 185.50p +4.80%Petra Diamonds Ltd.(DI) (PDL) 158.20p +4.42%AO World (AO.) 319.50p +4.28%Booker Group (BOK) 153.50p +3.44%Brown (N.) Group (BWNG) 448.60p +3.08%AL Noor Hospitals Group (ANH) 927.50p +3.00%Countrywide (CWD) 496.80p +2.88%Lonmin (LMI) 172.30p +2.62%Ultra Electronics Holdings (ULE) 1,778.00p +2.48%Howden Joinery Group (HWDN) 425.10p +2.46%FTSE 250 - FallersAfren (AFR) 11.10p -6.25%Premier Oil (PMO) 161.10p -5.79%Hunting (HTG) 456.20p -4.70%Wood Group (John) (WG.) 596.00p -4.03%Aveva Group (AVV) 1,390.00p -3.67%Ladbrokes (LAD) 120.10p -3.15%Thomas Cook Group (TCG) 126.10p -3.00%Interserve (IRV) 541.50p -2.96%Diploma (DPLM) 755.50p -2.58%Petrofac Ltd. (PFC) 742.50p -2.24%
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.